Abstract
Given the potent oxidizing strength of cytochrome P450 intermediates it is not surprising that certain substrates can give rise to reactive species capable of attacking the heme or critical distal pocket protein residues to irreversibly modify the enzyme in a process known as mechanism-based (MB) inactivation, a result that can have serious physiological consequences, leading to adverse drug-drug interactions and toxicity. While methods exist to document the attachment of these substrate fragments, it is more difficult to gain insight into the structural basis for the altered functional properties of these modified enzymes. In response to this pressing need to better understand MB inhibition, we here report the first application of resonance Raman spectroscopy to study the inactivation of a truncated form of mammalian CYP2B4 by the acetylenic inhibitor, 4-(tert-butyl)phenylacetylene (BPA), whose activated form is known to attach to the distal pocket T302 residue of the CYP2B4.
The membrane-bound human cytochromes P450, responsible for catalyzing the metabolism of pharmaceuticals or other xenobiotics,1 proceed through a complex cycle involving the sequential delivery of two electrons to a heme-bound dioxygen complex, effecting the splitting of the O-O bond to generate a potent oxygenating intermediate capable of inserting a single oxygen atom into the bound substrates, the nature of the putative intermediate generally being formulated as a ferryl heme π-cation similar to the Compound I species in the enzymatic cycles of the heme peroxidases.1 Given the impressive oxidizing strength of this species, it is not surprising that certain substrates give rise to reactive intermediates capable of attacking the heme or critical distal pocket protein residues to irreversibly modify the enzyme in a process known as mechanism-based (MB) inactivation.2 Some of the common compounds that fall into the category of MB inactivators are acetylenes, organosulfur compounds, arylamines, and others.2
Obviously, inasmuch as such irreversible inactivation can have profound physiological consequences leading to adverse drug-drug interactions or toxicity, it is important to gain structural insight into the altered functional behavior of these modified P450s. One of the most powerful techniques available for this purpose is resonance Raman (RR) spectroscopy, which is able to provide critical information about the heme active site structure, including reliable documentation of the iron oxidation and spin states3 and the disposition of bound exogenous ligands, permitting characterization of unstable intermediates such as the oxy, peroxo- and hydroperoxo-intermediates that arise in the P450 cycle.3–6 In response to this pressing need to better understand MB inhibition, we here report the first application of RR to study the inactivation of a truncated form of mammalian CYP2B4 by the acetylenic inhibitor, 4-(tert-butyl)phenylacetylene (BPA), whose activated form is known to attach to the distal pocket T302 residue of the CYP2B4 (Figure S1, Supporting Information).7
The high frequency RR spectra of the wild type substrate-free ferric enzyme (WT 2B4dH SF), as well as its adduct with the prototypical substrate benzphetamine (WT 2B4dH BZ), are shown in Figure 1. The spectrum of the SF sample (trace A) exhibits the oxidation state marker mode, ν4, at 1372 cm−1 and the ν3 and ν2 spin state markers at 1502 cm−1 and 1583 cm−1, respectively, confirming the presence of a ferric low-spin state.3,8 The addition of BZ (trace B) causes partial spin state conversion (seen as an increase in the intensity of the high spin ν3 mode at 1487 cm−1) associated with disruption of the distal pocket water cluster, data entirely consistent with the RR data previously reported for full-length ferric substrate-free and BZ-bound cytochrome 2B4.9 The spectrum the BPA-modified 2B4dH without added substrate (modified-2B4dH SF, trace C) exhibits a spectral pattern essentially identical to that of the WT sample, indicating that the enzyme modification has no substantial impact on the resting state heme structure. The first interesting observation is that addition of substrate (BZ) to BPA modified-2B4dH causes no changes in heme spin state or macrocyclic core structure, as judged by virtually identical RR spectra (traces C and D), the lack of such changes for the modified form being consistent with the blocking of substrate access by the attached BPA fragment.7 As is shown in Supporting Information (Figure S2), the low frequency RR spectral data also confirm the lack of significant changes associated with attached fragment and the apparent blocking of BZ access to the active site
It is also of obviously important to interrogate the ligated forms of this modified protein. While the oxy and reduced oxy intermediates are generally quite unstable,1 the stable ferrous CO form is readily characterized by RR measurements. This form mimics the physiologically relevant oxy form, providing important information about the heme moiety and distal side pocket structure that can affect ligand-protein interactions.8–16 Figure 2 shows the low frequency RR spectra of the CO adducts, where the ν(Fe-CO) stretching and δ(Fe-C-O) bending modes are observed, and the high frequency region containing the ν(C-O) mode. The spectrum of SF WT 2B4dH (trace A) exhibits a strong ν(Fe-CO) stretching mode at 471 cm−1 and a δ(Fe-C-O) bending mode at 558 cm−1 (trace A), with the corresponding ν(C-O) mode occurring at 1950 cm−1. Addition of BZ causes a small 2 cm−1 downshift of the ν(Fe-CO) mode (trace B), the magnitude of the shift being similar to those observed previously in full-length 2B4;9 the ν(C-O) mode shifts up slightly to 1953 cm−1. Of greatest significance is the relatively large 6 cm−1 down shift of the Fe-CO mode observed for SF modified-2B4 (trace C), with the corresponding ν(C-O) stretching mode being upshifted by 9 cm−1 to 1959 cm−1, both shifts implying a substantial decrease in distal heme pocket polarity and weakening of any possible H-bonding interaction; these data provide the first direct spectroscopic evidence that the fragment is positioned in such a way as to impact the disposition of bound exogenous ligands, presumably relevant also for the dioxygen adduct and the key peroxo- and hydroperoxo- fragments. Finally, the addition of benzphetamine to the modified protein sample (spectrum D) does not affect the Fe-CO mode (the difference pattern between the spectra of the modified protein with and without BZ is featureless), a result which further supports the conclusion drawn from study of the ferric forms (Figure 1) that the attached BPA fragment blocks the entrance of substrate into the heme cavity.
In addition to these changes in the Fe-C-O fragment, careful spectroscopic interrogation of these samples reveals additional changes in the “vinyl bending” modes. In the case of WT 2B4dH (trace A) there are two vinyl bending modes at 410 cm−1 and 419 cm−1, whereas in the spectrum of the modified protein (trace C) there is only one vinyl bending mode observed at 418 cm−1, the lower frequency mode having apparently shifted to a position near the higher one. Similar behavior is seen in high frequency region where ν(C=C) stretching modes are observed; in the spectra of the modified protein, the lower frequency mode at 1620 cm−1 loses its intensity while the mode at 1634 cm−1 gains intensity as compared to the spectra of WT protein (Figure S3, Supporting Information). The lower frequency vinyl bending and stretching modes are commonly associated with the in-plane configuration of vinyl groups, while the higher frequency bands are associated with out-of-plane orientations.17 This demonstrated ability to document changes in these vinyl bending and stretching modes is therefore of special importance, because the orientation of the vinyl groups with respect to the plane of the heme macrocyle has been suggested to carry functional significance by modifying the heme reduction potential and affinity for axial ligands.18,19
The changes seen in the behavior of modes of the Fe-C-O fragment are useful indicators of distal pocket structure.10–16 The ν(Fe-CO) and ν(C-O) stretching frequencies in heme proteins usually follow an inverse correlation, reflecting Fe-CO back-bonding, as shown in the inset of Figure 2.10–16 The magnitudes of such shifts are influenced by the strength of the trans-proximal ligand bond and the polarity of the distal pocket environment; i.e., positive charge (including H-bonding) increases the ν(Fe-CO) frequencies and decreases the ν(C-O) frequencies along the correlation, while its elimination has the opposite effect.10–16 The comparison of newly obtained data for the CO adducts of modified 2B4 with previously published data locates the ν(Fe-CO)/ν(C-O) points obtained for the samples studied here (dotted line, inset of Figure 2) only slightly below the line previously derived for cytochrome P450cam samples (solid line, inset of Figure 2); the implied strongly nonpolar environment on the distal site of heme moiety is obviously most reasonably associated with the presence of the attached apolar BPA fragment.
In summary, the acquired RR data confirm that the BPA modification of 2B4dH protein does not substantially alter the resting state heme structure, but does block the BZ substrate from entrance to the distal pocket. Most importantly, the present studies of the CO ligated forms convincingly demonstrate the impressive potential of RR spectroscopy to effectively document even small structural changes associated with MB inhibition, including alterations in axial ligand disposition, heme macrocycle deformation and variations in vinyl group orientation, changes that could potentially lead to differences in reduction potential or affinity for axial ligands and impact the stability of key peroxo-and hydroperoxo- intermediates.
Supplementary Material
Acknowledgments
This work was supported by grants from National Institutes of Health (DK35153 to J.R.K. and CA16954 to P.F.H.).
Footnotes
Supporting Information Available: Active site structure, low frequency RR spectra of SF and BZ-bound P450 2B4 and modified enzyme; high frequency RR spectra of CO adducts, showing the vinyl stretching modes. The material is available free of charge via the internet at htpp://pubs.acs.org.
REFERENCES
- 1.Sigel A, Sigel H, Sigel RKO, editors. Metal Ions in Life Sciences. Vol 3. John Wiley & Sons, Ltd.; 2007. [Google Scholar]
- 2.Hollenberg PF, Kent UM, Bumpus NN. Chem. Res. Toxicol. 2008;21:189–205. doi: 10.1021/tx7002504. [DOI] [PubMed] [Google Scholar]
- 3.Spiro TG, editor. Biological Applicfations of Raman Spectroscopy. John Wiley & Sons; 1988. [Google Scholar]
- 4.Hu S, Schneider A, Kincaid JR. J. Am. Chem. Soc. 1991;113:4815–4822. [Google Scholar]
- 5.Mak PJ, Denisov IG, Victoria D, Makris TM, Deng T, Sligar SG, Kincaid JR. J. Am. Chem. Soc. 2007;129:6382–6383. doi: 10.1021/ja071426h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Denisov IG, Mak PJ, Makris TM, Sligar SG, Kincaid JR. J. Phys. Chem. A. 2008;112:13172–13179. doi: 10.1021/jp8017875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhang H, Lin H-L, Walker VJ, Hamdane D, Hollenberg PF. Mol. Pharmacol. 2009;76:1011–1018. doi: 10.1124/mol.109.059808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Wells AV, Li P, Champion PM, Martinis SA, Sligar SG. Biochemistry. 1992;31:4384–4393. doi: 10.1021/bi00133a002. [DOI] [PubMed] [Google Scholar]
- 9.Mak PJ, Im S-C, Zhang H, Waskell LA, Kincaid JR. Biochemistry. 2008;47:3950–3963. doi: 10.1021/bi800034b. [DOI] [PubMed] [Google Scholar]
- 10.Uno T, Nishimura Y, Makino R, Iizuka T, Ishimura Y, Tsuboi M. J. Biol. Chem. 1985;260:2023–2026. [PubMed] [Google Scholar]
- 11.Jung C, Hoa GH, Schroder KL, Simon M, Doucet JP. Biochemistry. 1992;31:12855–12862. doi: 10.1021/bi00166a021. [DOI] [PubMed] [Google Scholar]
- 12.Hu S, Kincaid JR. J. Am. Chem. Soc. 1991;113:2843–2850. [Google Scholar]
- 13.Bangcharoenpaurpong O. Ph.D. Dissertation. Boston, MA: Northeastern University; 1987. [Google Scholar]
- 14.Ray GB, Li X-Y, Ibers JA, Sessler JL, Spiro TG. J. Am. Chem. Soc. 1994;116:162–176. [Google Scholar]
- 15.Spiro TG, Wasbotten IH. J. Inorg. Biochem. 2005;99:34–44. doi: 10.1016/j.jinorgbio.2004.09.026. [DOI] [PubMed] [Google Scholar]
- 16.Ibrahim M, Xu C, Spiro TG. J. Am. Chem. Soc. 2006;128:16834–16845. doi: 10.1021/ja064859d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Chen Z, Ost TWB, Schelvis JPM. Biochemistry. 2004;43:1798–1808. doi: 10.1021/bi034920g. [DOI] [PubMed] [Google Scholar]
- 18.Lee KB, Jun E, La Mar GN, Rezzano IN, Pandey RK, Smith KM, Walker FA, Buttlaire DH. J. Am. Chem. Soc. 1991;113:3576–3583. [Google Scholar]
- 19.Reid LS, Lim AR, Mauk AG. J. Am. Chem. Soc. 1986;108:8197–8201. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.